
321839-75-2 CrineCerfont
Non pwodwi: CrineCerfont
CAS: 321839-75-2
MF: C27H29CL2FN2OS
MW: 519.5
Einecs:
MDL No.:MFCD05260970
Pwopriyete
Aparans limyè jòn poud jòn
Depo tanperati. 4 degre, lwen imidite ak limyè
Aplikasyon:
CrineCerfont (SSR -125543) se yon efikas oral aktif, ki pa peptides antagonist reseptè CRF1 prensipalman itilize pou tretman nan konjenital hyperplasia adrenal (CAH). Crinecerfont inibit sekresyon pitwitèr nan òmòn adrenokortikotwopik (ACTH) pa bloke obligatwa nan kortikotropin divilge faktè (CRF) nan reseptè CRF1 nan glann pitwitèr la, kidonk diminye ACTH medyatè adrenal pwodiksyon androjèn ak ede kontwole akrojèn nan adrenal adrenal adrenal ak adrenal nan plis
Sinonim:
321839-75-2
Crinecerfont (hydrochlorid)
4- (2- chloro -4- methoxy -5- methylphenyl) -n-[(1s) -2- cyclopropyl -1- (3- fluor {{}} } methylphenyl) etil] -5- methyl-n-prop -2- ynyl -1, 3- thiazol -2- amine; hydrochloride
(S) -4- (2- chloro -4- methoxy -5- methylphenyl) -n-(2- cyclopropyl -1- (3- } fluoro -4- methylphenyl) etil) -5- methyl-n- (prop -2- ynyl) thiazol -2- amine idroklorur
4- (2- chloro -4- methoxy -5- methylphenyl) -n-[(1s) -2- Cyclopropyl -1- (3- Fuuor o -4- methylphenyl) etil] 5- methyl-n-(2- propynyl) -1, 3- thiazol -2- amine idroklorur
Baj popilè: 321839-75-2 CrineCerfont, Lachin 321839-75-2 Konpayi fabrikasyon CrineCerfont, Swèd

